ArticleClinical Medicine Insights. Oncology2020

Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation.

Cheng-Maw Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.